Eisler Capital (UK)’s Regeneron Pharmaceuticals REGN Stock Holding History

Eisler Capital (UK)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$46.2M	Buy	43,962 +1,490	+4%	+$1.66M	0.21%	100
2024 Q2	$44.6M	Buy	42,472 +29,896	+238%	+$29M	0.29%	85
2024 Q1	$12.1M	Buy	12,576 +3,061	+32%	+$2.91M	0.1%	192
2023 Q4	$8.36M	Buy	9,515 +8,706	+1,076%	+$7.17M	0.06%	227
2023 Q3	$666K	Buy	+809	New	+$636K	﹤0.01%	417
2022 Q2	–	Sell	-27,500	Closed	-$19.2M	–	510
2022 Q1	$19.2M	Buy	27,500 +12,500	+83%	+$7.91M	0.32%	87
2021 Q4	$9.48M	Buy	+15,000	New	+$9.22M	0.47%	59

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Eisler Capital (UK)'s REGN Position: Q3 2024 in Review

Eisler Capital (UK) opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2024: 484 shares worth $509K. The stake represents ﹤0.01% of the portfolio and ranks #528 among its holdings. This is a return to the name: Eisler Capital (UK) previously reported a position in REGN as recently as Q1 2024.

Eisler Capital (UK) first reported a position in REGN in Q4 2021 and has held it in 4 quarters since. The position peaked at $2.06M in Q4 2021. 1,388 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

Eisler Capital (UK) held 484 shares of Regeneron Pharmaceuticals worth $509K as of Q3 2024.
Regeneron Pharmaceuticals was a new Eisler Capital (UK) position in Q3 2024.
Regeneron Pharmaceuticals made up ﹤0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #528 holding.
Eisler Capital (UK) first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 4 quarters since.
Eisler Capital (UK)'s Regeneron Pharmaceuticals position peaked at $2.06M in Q4 2021.
1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.